NanoFUSE Biologics

NanoFUSE Biologics is a leader in medical equipment manufacturing, specializing in regenerative therapeutics designed to replace and regenerate human bone cells, facilitating the formation of normal bone. NanoFuse Biologics LLC, owned by NANISX LLC, offers NanoFuse® DBM, an FDA-approved combination of synthetic bioactive ceramic 45S5 bioglass and demineralized bone matrix (DBM) that enhances bone regeneration, promoting fusion and healing.

Located at 350 Main St, Malden, Massachusetts 02148, US, NanoFUSE Biologics leverages innovative technologies. When NanoFuse® DBM combines with aqueous body fluid, it forms a 3D ultra-porous calcium hydroxyapatite layer within 24 hours, creating a strong bond with adjacent bone. This process triggers osteoblast differentiation, accelerates osteogenesis, and enhances bone growth. Furthermore, in vitro studies indicate that ionic release (Ca) and pH changes inherent to bioactive glass create an antimicrobial environment.

Guided by LESS™ Exposure Spine Surgery (LESS) principles and the Restore Function, Early Intervention, and Preserve Anatomy (REP) methodology, NanoFUSE Biologics is a trusted bone void filler for fusion and regeneration. With a proven clinical record and patented manufacturing, NanoFUSE Biologics LLC delivers reliable bone regeneration solutions. We invite the manager of NanoFUSE Biologics to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.